| Institute |
|---|
| Helmholtz Munich Core Facility Monoclonal Antibodies |
| SKU: | 162378 |
|---|---|
| Product description: | Antibody for PCNA (proliferating cell nuclear antigen), a key protein involved in cell cycle regulation, particularly during DNA replication and repair. Its dysregulation is linked to cancer development. |
| Alternate name: | Anti PCNA (clone 16D10) |
| Conjugation: | Unconjugated |
| Immunogen: | Recombinant 6xHis-tagged PCNA |
| Cat. #: | 162378 |
|---|---|
| Tool sub type: | Primary antibody |
| Cancer types: | Breast cancer |
| Research Fields: | Cancer; Cell biology |
| Application: | IP |
| Target: | Proliferating Cell Nuclear Antigen (PCNA) |
| Reactivity: | Human |
| Clone: | 16D10 |
| Host: | Rat |
| Class: | Monoclonal |
| Primary citation: | Spada et al. 2007. J Cell Biol. 176(5): 565-71. PMID: 17312023 |
| Target background: | PCNA (Proliferating Cell Nuclear Antigen) is a sliding clamp for DNA polymerases during DNA replication that coordinates the orderly duplication of the genome by increasing the processivity of DNA polymerase delta. PCNA weighs approximately 29 kDa and forms a homotrimeric ring structure. It is expressed in the nucleus of cells found at high levels in proliferating cells. |
|---|
| References: |
Spada et al. 2007. J Cell Biol. 176(5): 565-71. PMID: 17312023 |
|---|
| Cat. # | Tool Name | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151026 | Anti-FCGR1 [10.1] mAb |
Key Info
Anti-FCGR1 [10.1] mAb
|
View Tool | |||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||
| 151019 | Anti-Mos [S3.1] |
Key Info
Anti-Mos [S3.1]
|
View Tool | |||||||||||||||
| 151035 | Anti-CD8 [14] mAb |
Key Info
Anti-CD8 [14] mAb
|
View Tool | |||||||||||||||
| 151040 | Anti-Integrins aL, aX, aMb2 [24] |
Key Info
Anti-Integrins aL, aX, aMb2 [24]
|
View Tool | |||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.